Insulin-mediated regulation of the endothelial renin–angiotensin system and vascular cell growth
暂无分享,去创建一个
T. Ogihara | J. Higaki | H. Rakugi | Y. Kawano | S. Takiuchi | K. Kamide | N. Matsukawa | M. Tuck | M. Nagai
[1] T. Ogihara,et al. Role of endothelin-1 induced by insulin in the regulation of vascular cell growth. , 2003, American journal of hypertension.
[2] T. Ogihara,et al. [Role of angiotensin in the metabolic syndrome and cardiovascular complications]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.
[3] P. Poredos,et al. Endothelial dysfunction in the pathogenesis of atherosclerosis. , 2002, International angiology : a journal of the International Union of Angiology.
[4] K. Egashira. Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[5] T. Ogihara,et al. Vascular signaling pathways in the metabolic syndrome , 2002, Current hypertension reports.
[6] K. Kamide,et al. Insulin and insulin‐like growth factor‐I promotes angiotensinogen production and growth in vascular smooth muscle cells , 2000, Journal of hypertension.
[7] G. King,et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. , 2000, Circulation.
[8] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[9] K. Kamide,et al. Insulin-mediated growth in aortic smooth muscle and the vascular renin-angiotensin system. , 1998, Hypertension.
[10] C. Kahn,et al. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. , 1997, The Journal of clinical investigation.
[11] T. Ogihara,et al. Insulin resistance is related to silent cerebral infarction in patients with essential hypertension. , 1997, American journal of hypertension.
[12] T. Ogihara,et al. Insulin resistance and cardiovascular complications in patients with essential hypertension. , 1996, American journal of hypertension.
[13] T. Ogihara,et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. , 1996, American heart journal.
[14] G. Dagenais,et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.
[15] G M Steil,et al. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process. , 1996, The Journal of clinical investigation.
[16] G. Reaven,et al. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.
[17] Y. Miyazaki,et al. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. , 1995, American journal of hypertension.
[18] H. Cheung,et al. Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca. , 1973, Biochimica et biophysica acta.
[19] E. Nabel,et al. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury. , 1995, The Journal of clinical investigation.
[20] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .